Private Advisor Group’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-85,000
Closed -$47.4K 2926
2026
Q1
$47.4K Hold
85,000
﹤0.01% 2582
2025
Q4
$66.6K Sell
85,000
-38,000
-31% -$27.6K ﹤0.01% 2506
2025
Q3
$79.8K Hold
123,000
﹤0.01% 2427
2025
Q2
$90.9K Buy
123,000
+8,000
+7% +$4.55K ﹤0.01% 2324
2025
Q1
$54K Hold
115,000
﹤0.01% 2231
2024
Q4
$50.9K Buy
115,000
+15,000
+15% +$7.26K ﹤0.01% 2212
2024
Q3
$67.6K Buy
100,000
+15,000
+18% +$9.92K ﹤0.01% 2337
2024
Q2
$53.5K Buy
85,000
+47,500
+127% +$37.9K ﹤0.01% 2269
2024
Q1
$43.9K Buy
37,500
+27,500
+275% +$30.2K ﹤0.01% 2249
2023
Q4
$11.3K Buy
+10,000
New +$11.8K ﹤0.01% 2208
2022
Q2
Sell
-10,000
Closed -$7K 2265
2022
Q1
$7K Buy
+10,000
New +$6.54K ﹤0.01% 2083

Other funds holding XTNT

Private Advisor Group's XTNT Position: Q2 2026 in Review

Private Advisor Group sold out of Xtant Medical Holdings (XTNT) in Q2 2026, closing a stake of 85,000 shares — an estimated $47.4K sold.

Private Advisor Group first reported a position in XTNT in Q1 2022 and held it in 11 quarters. The position peaked at $90.9K in Q2 2025. 4 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

  • Private Advisor Group reported no remaining Xtant Medical Holdings position as of Q2 2026 after selling out during the quarter.
  • Private Advisor Group sold 85,000 Xtant Medical Holdings shares in Q2 2026, an estimated $47.4K.
  • Private Advisor Group first reported a position in Xtant Medical Holdings in Q1 2022 and held it in 11 quarters.
  • Private Advisor Group's Xtant Medical Holdings position peaked at $90.9K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.